Xintela AB
Biomedical company developing stem cell therapies for regenerative medicine and oncology.
XINT | ST
Overview
Corporate Details
- ISIN(s):
- SE0007756903 (+2 more)
- LEI:
- 549300SMDH1EOLCBQU68
- Country:
- Sweden
- Address:
- MEDICON VILLAGE, 223 81 Lund
- Website:
- https://xintela.se/
Description
Xintela AB is a biomedical company active in regenerative medicine and oncology. The company's technology platform is centered on the cell surface marker integrin α10β1, which is utilized to select and quality-assure therapeutic stem cells. Its primary product candidate, XSTEM®, is an allogeneic mesenchymal stem cell therapy. XSTEM® is currently in Phase I/IIa clinical development for the treatment of knee osteoarthritis and difficult-to-heal venous leg ulcers. The oncology pipeline focuses on developing targeted cancer therapies, particularly for aggressive brain tumors such as glioblastoma.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Xintela AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Xintela AB
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Xintela AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
